The Future of
Medical AI
Delivered Weekly
Curated research insights for clinicians and patients. No hype. Just evidence.

Clinically distinct genetic diseases converge on shared, druggable nodes
MIT researchers have developed an AI tool that finds common drug targets for different genetic diseases, potentially speeding up new treatments in the coming years.
Why Medical Professionals Choose Mednosis
We cut through the noise to deliver research that actually matters
Built for Clinicians
Technical notes include study design, sample sizes, confidence intervals, and key limitations
Patient-Friendly
Every article includes plain language explanations your patients can understand
Zero Hype Guarantee
Practice impact ratings tell you exactly how close research is to clinical reality
Latest Research

Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes

Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks

Preventive vaccines for hereditary cancer syndromes

To succeed with AI, leaders must prioritize safety when driving transformation

Your Watch Will One Day Track Blood Pressure

The 11 Medical Specialties With The Biggest Potential In The Future
Get smarter about medical AI every week
Join clinicians and researchers staying ahead of the curve
Trending This Week
Research getting the most attention

Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes

Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks
A geometric feature tracking approach for noninvasive patient specific estimation of leaflet strain from 3D images of heart valves
Find What Matters to You
Filter research by how close it is to clinical practice
Browse by Specialty
Find research relevant to your field
Never Miss a
Breakthrough
Get curated AI in medicine research delivered weekly. No spam, unsubscribe anytime.
AI in Medicine 101
Learn how to read medical AI research, spot red flags in hype-y articles, and ask the right questions about new technologies.